Drug
Trametinib Daily Until PD
Trametinib Daily Until PD: highest development phase Phase 1/2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Trametinib daily Until PD NCT03580382 | Phase 1/2 | Melanoma |
Latest
No recent events.
Follow Trametinib Daily Until PD on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.